StockTipsArenaBeta

BUY Ajanta Pharma Limited — Aastha Jain, Hem Securities

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: BTST30 Sept 2026, 11:22 am ISTvia Zee Business (Live)

Entry₹3,621.6Inferred
Target₹3,800
Total upside +4.93% (call closed)
Stop loss₹3,566-1.54% risk
Exit₹3,5661 Oct 2026, 9:16 am
Stop-loss hit-1.54%
Follow Aastha Jain for new calls(25% target hit, 84 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 5 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 1 Oct 2026
3 supporting0 opposing
Supports the BUY call (3)

Ajanta Pharma promoter releases pledge on 98,185 shares for loan repayment

NewsGoogle News·28 Sept · 2d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·24 Sept · 6d ago

Ajanta Pharma's Geographical Diversification Delivers

NewsGoogle News·23 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Aastha Jain, Hem Securities

Every call and its outcome